| Dr Cinthia I Drachenberg, MD | |
|
22 S Greene St, Baltimore, MD 21201-1544 | |
| (667) 214-1608 | |
| (410) 328-0929 |
| Full Name | Dr Cinthia I Drachenberg |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 42 Years |
| Location | 22 S Greene St, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720017478 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0101X | Pathology - Anatomic Pathology | D0040130 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Maryland Medical Center | Baltimore, MD | Hospital |
| University Of Md Baltimore Washington Medical Center | Glen burnie, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Univ Of Md Pathology Associates P A | 7517853377 | 12 |
News Archive
Telik, Inc. today reported financial results for the first quarter ended March 31, 2010. The net loss for the quarter ended March 31, 2010 was $5.3 million, or $0.10 per share, compared with a net loss of $7.7 million, or $0.14 per share, for the same period in 2009.
The key to balance is, in part, the ability to overpower your mind. Your brain possesses what some researchers call "common drive." It wants to activate and relax all muscles in synchrony, including the opposing ones.
Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of serious multi-drug-resistant infections, announced today it has entered into a further license agreement with Yale University in the area of ribosome and antibiotic structure and function.
Researchers have shown that maternal age may not influence the implantation potential of embryos in IVF or the likelihood of miscarriage.
› Verified 4 days ago
| Entity Name | Univ Of Md Pathology Associates P A |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740219401 PECOS PAC ID: 7517853377 Enrollment ID: O20040226001249 |
News Archive
Telik, Inc. today reported financial results for the first quarter ended March 31, 2010. The net loss for the quarter ended March 31, 2010 was $5.3 million, or $0.10 per share, compared with a net loss of $7.7 million, or $0.14 per share, for the same period in 2009.
The key to balance is, in part, the ability to overpower your mind. Your brain possesses what some researchers call "common drive." It wants to activate and relax all muscles in synchrony, including the opposing ones.
Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of serious multi-drug-resistant infections, announced today it has entered into a further license agreement with Yale University in the area of ribosome and antibiotic structure and function.
Researchers have shown that maternal age may not influence the implantation potential of embryos in IVF or the likelihood of miscarriage.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Cinthia I Drachenberg, MD 250 W Pratt St Ste 780, Baltimore, MD 21201-2470 Ph: (667) 214-1608 | Dr Cinthia I Drachenberg, MD 22 S Greene St, Baltimore, MD 21201-1544 Ph: (667) 214-1608 |
News Archive
Telik, Inc. today reported financial results for the first quarter ended March 31, 2010. The net loss for the quarter ended March 31, 2010 was $5.3 million, or $0.10 per share, compared with a net loss of $7.7 million, or $0.14 per share, for the same period in 2009.
The key to balance is, in part, the ability to overpower your mind. Your brain possesses what some researchers call "common drive." It wants to activate and relax all muscles in synchrony, including the opposing ones.
Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of serious multi-drug-resistant infections, announced today it has entered into a further license agreement with Yale University in the area of ribosome and antibiotic structure and function.
Researchers have shown that maternal age may not influence the implantation potential of embryos in IVF or the likelihood of miscarriage.
› Verified 4 days ago
Serena Maria Bagnasco, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 4940 Eastern Ave, Baltimore, MD 21224 Phone: 410-955-2660 | |
Dr. Adeboye Oluwaseyi Osunkoya, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 401 N Broadway, Johns Hopkins Pathology , Weinberg Room 2242, Baltimore, MD 21231 Phone: 405-808-5361 | |
Michael T. O'malley, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 2401 W Belvedere Ave, Baltimore, MD 21215 Phone: 410-644-4379 Fax: 410-644-4325 | |
Michael Edward Kallen, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 401 N Broadway St, Baltimore, MD 21287 Phone: 410-955-3580 Fax: 410-614-1287 | |
Deyin Xing, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 401 North Broadway, Weinberg 2268, Baltimore, MD 21231 Phone: 410-955-3580 Fax: 410-614-1287 | |
Matthew Grant Gabrielson, Pathology Medicare: Medicare Enrolled Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-3980 | |
Robert A. Palermo, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 6701 N Charles St, Baltimore, MD 21204 Phone: 443-849-2257 Fax: 443-849-3016 |